{"id":10744,"date":"2015-07-01T00:00:00","date_gmt":"2015-06-30T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2015\/07\/01\/ferrer-y-el-idibell-desarrollan-epicup-el-primer-test-epigenetico-para-pacientes-con-cancer-de-origen-desconocido\/"},"modified":"2020-05-20T16:05:51","modified_gmt":"2020-05-20T14:05:51","slug":"ferrer-y-el-idibell-desarrollan-epicup-el-primer-test-epigenetico-para-pacientes-con-cancer-de-origen-desconocido","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2015\/07\/ferrer-y-el-idibell-desarrollan-epicup-el-primer-test-epigenetico-para-pacientes-con-cancer-de-origen-desconocido\/","title":{"rendered":"Ferrer y el IDIBELL desarrollan EPICUP, el primer test epigen\u00e9tico para pacientes con c\u00e1ncer de origen desconocido"},"content":{"rendered":"
metilaci\u00f3n del ADN y ayuda al m\u00e9dico onc\u00f3logo a Sobre Ferrer<\/p>\n","protected":false},"author":6,"featured_media":10745,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,286],"tags":[],"class_list":["post-10744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-epigenetica-del-cancer-cancer"],"publishpress_future_action":{"enabled":false,"date":"2025-05-23 17:19:34","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10744"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10745"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
identificar el tumor primario en pacientes con c\u00e1ncer de origen desconocido (CUP, seg\u00fan su sigla en ingl\u00e9s).
La herramienta, fruto de la colaboraci\u00f3n p\u00fablico-privada entre el Programa de Epigen\u00e9tica y Biolog\u00eda del C\u00e1ncer del Institut d’Investigaci\u00f3 Biom\u00e9dica de Bellvitge (IDIBELL) dirigido por Manel Esteller, la Unidad de Innovaci\u00f3n del IDIBELL y el \u00e1rea de innovaci\u00f3n y desarrollo de negocio de FERRER, presenta un alto grado de exactitud. As\u00ed pues, EPICUP se convierte en un buen complemento a las metodolog\u00edas diagn\u00f3sticas actualmente utilizadas.
Seg\u00fan la Organizaci\u00f3n Mundial de la Salud, el c\u00e1ncer es la principal causa de muerte en el mundo y se prev\u00e9 un aumento entre 2007 y 2030 del 45%, lo que supondr\u00e1 m\u00e1s de 15 millones de nuevos casos y 11.3 millones de defunciones. \u201cSi bien en la \u00faltima d\u00e9cada\u201d explica Manel Esteller \u201cse han conseguido progresos muy importantes en lo que respecta al diagn\u00f3stico de la enfermedad, aun hoy, el 5% de los pacientes con c\u00e1ncer ser\u00e1n diagnosticados de c\u00e1ncer de origen desconocido\u201d.
\u201cEstos pacientes no solo presentan un pron\u00f3stico desfavorable\u201d, a\u00f1ade Carmen Bala\u00f1\u00e1 del Institut Catal\u00e0 d\u2019Oncologia Germans Trias i Pujol, \u201csino que adem\u00e1s ante el desconocimiento del tumor que dio origen a la met\u00e1stasis, se les administra un tratamiento de forma emp\u00edrica. Hecho, que en muchos casos, repercutir\u00e1 de forma negativa tanto en la evoluci\u00f3n de la enfermedad como en la calidad de vida del paciente\u201d.
Conscientes de esta realidad, IDIBELL y FERRER han desarrollado EPICUP con la finalidad de ayudar a diagnosticar el tumor primario y por consiguiente a que el m\u00e9dico onc\u00f3logo pueda establecer la pauta terap\u00e9utica m\u00e1s apropiada en cada caso. Asimismo, destaca Esteller \u201cactualmente estamos trabajando en la b\u00fasqueda de perfiles de metilaci\u00f3n que nos ayuden a identificar a qu\u00e9 tratamientos podr\u00eda ser sensible el tumor en cuesti\u00f3n, cuyo objetivo ser\u00e1 complementar en el corto\/mediano plazo a EPICUP\u201d.
This project has received funding from the European Research Council (ERC) under the European Union\u2019s Horizon 2020 research and innovation programme (grant agreement No 640696).<\/span>
FERRER es una compa\u00f1\u00eda qu\u00edmico-farmac\u00e9utica con sede en Barcelona. Fundada en 1959, el grupo abarca hoy 45 empresas que desarrollan sus actividades en Europa, Am\u00e9rica Latina, \u00c1frica, Oriente Medio, Asia y Estados Unidos. En total, los productos de salud de FERRER se comercializan en 93 pa\u00edses a trav\u00e9s de 26 filiales directas (incluyendo empresas conjuntas) y 70 socios y distribuidores.
FERRER lleva a cabo actividades a lo largo de toda la cadena de valor del medicamento, desde la I+D hasta la comercializaci\u00f3n internacional, incluido el desarrollo de productos de qu\u00edmica fina, y la fabricaci\u00f3n de materias primas y productos farmac\u00e9uticos.<\/p>\n","protected":false},"excerpt":{"rendered":"